Therefore, this study aimed to investigate whether the iFGF23:cFGF23 ratio, as a marker of FGF23 intracellular degradation, could differentiate AKI from CKD in patients presenting to a nephrology unit. This evidence concerns the gene FGF23 and acute kidney injury.